ECSP18006622A - DERIVATIVES OF 2,3-DIHIDRO-4H-1,3-BENZOXAZIN-4-ONA AS MODULATORS OF MUSCARINIC M1 CHOLINERGIC RECEPTOR - Google Patents

DERIVATIVES OF 2,3-DIHIDRO-4H-1,3-BENZOXAZIN-4-ONA AS MODULATORS OF MUSCARINIC M1 CHOLINERGIC RECEPTOR

Info

Publication number
ECSP18006622A
ECSP18006622A ECIEPI20186622A ECPI201806622A ECSP18006622A EC SP18006622 A ECSP18006622 A EC SP18006622A EC IEPI20186622 A ECIEPI20186622 A EC IEPI20186622A EC PI201806622 A ECPI201806622 A EC PI201806622A EC SP18006622 A ECSP18006622 A EC SP18006622A
Authority
EC
Ecuador
Prior art keywords
muscarinic
dihidro
benzoxazin
ona
modulators
Prior art date
Application number
ECIEPI20186622A
Other languages
Spanish (es)
Inventor
Jinichi Yonemori
Masaki Ogino
Kenichiro Shimokawa
Eiji Kimura
Makoto Kamata
Hiroki Sakamoto
Masataka Murakami
Takahiro Sugimoto
Minoru Nakamura
Shinkichi Suzuki
Takuto Kojima
Masami Yamada
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of ECSP18006622A publication Critical patent/ECSP18006622A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona un compuesto con una actividad moduladora alostérica positiva del receptor muscarínico colinérgico M1, que puede ser útil como un fármaco preventivo o terapéutico para enfermedad de Alzheimer, esquizofrenia, dolor, trastorno del sueño, demencia por enfermedad de Parkinson, demencia por cuerpos de Lewy, y similares. La presente invención se refiere a un compuesto representado por la fórmula (I) (descrita en el adjunto a este casillero) o una de sus sales en donde cada símbolo es como se define en la descripción adjunta.The present invention provides a compound with a positive allosteric modulatory activity of the muscarinic cholinergic M1 receptor, which may be useful as a preventive or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, body dementia Lewy, and the like. The present invention relates to a compound represented by formula (I) (described in the attachment to this box) or a salt thereof wherein each symbol is as defined in the attached description.

ECIEPI20186622A 2015-06-26 2018-01-26 DERIVATIVES OF 2,3-DIHIDRO-4H-1,3-BENZOXAZIN-4-ONA AS MODULATORS OF MUSCARINIC M1 CHOLINERGIC RECEPTOR ECSP18006622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015129043 2015-06-26

Publications (1)

Publication Number Publication Date
ECSP18006622A true ECSP18006622A (en) 2018-04-30

Family

ID=59981587

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI20186622A ECSP18006622A (en) 2015-06-26 2018-01-26 DERIVATIVES OF 2,3-DIHIDRO-4H-1,3-BENZOXAZIN-4-ONA AS MODULATORS OF MUSCARINIC M1 CHOLINERGIC RECEPTOR

Country Status (2)

Country Link
AR (1) AR105106A1 (en)
EC (1) ECSP18006622A (en)

Also Published As

Publication number Publication date
AR105106A1 (en) 2017-09-06

Similar Documents

Publication Publication Date Title
DOP2017000309A (en) DERIVATIVES OF 2,3-DIHIDRO-4H-1,3-BENZOXAZIN-4-ONA AS M1 CHOLINERGIC MUSCARINIC RECEIVER MODULATORS
ECSP16090152A (en) HETEROCYCLIC COMPOUND CONTAINING NITROGEN
GT201400301A (en) 7H-PIRROLO [2,3-D] PYRIMIDINS-4- (AMINHO-SUBSTITUTES) NOVELTY AS INHIBITORS OF LRRK2
UY35377A (en) 1,3-OXAZIN-2-AMINA COMPOUNDS FUSED WITH PERFLUORATED CYCLOPROPYL AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
CO2019007835A2 (en) Bis-heteroaryl derivatives as modulators of protein aggregation
MX2016012008A (en) Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders.
CO2017004465A2 (en) 2-amino-6- (difluoromethyl) -5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
CO2019007830A2 (en) Bicyclic bis-heteroaryl derivatives as protein aggregation modulators
GT201500092A (en) ROR-GAMMA-T PHENYLED UNITED FINYLIN MODULATORS
UY36263A (en) TIAZIN-2-AMINA COMPOUNDS FUSED WITH CYCLOPROPYL AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
MX2019007104A (en) DERIVATIVES OF 1,4-THIAZINE DIOXIDE AND 1,2,4-TIADIAZINE DIOXIDE AS BETA-SECRETASE INHIBITORS AND METHODS OF USE.
CL2016000019A1 (en) Compounds derived from deuterated dihydroxyphenyl or a salt thereof; pharmaceutical composition that comprises them and their use for the treatment of neurotransmitter-mediated disorders such as hypotension, sleep disorders, Alzheimer's disease and depression.
DOP2016000290A (en) HETEROAROMATIC COMPOUNDS AND ITS USE AS DOPAMINE DIGINATES D1
SV2017005354A (en) QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS
DOP2016000289A (en) HETEROAROMATIC COMPOUNDS AND ITS USE AS DOPAMINE DIGINATES D1
MX2019007101A (en) Oxazine derivatives as beta-secretase inhibitors and methods of use.
MX2019007102A (en) Thiazine derivatives as beta-secretase inhibitors and methods of use.
CR20150646A (en) 4- (5- (4-CHLOROPHENYL) -2- (2-CYCLOPROPYLACETIL) -1,4-DIMETHYL-1H-PIRROL-3-IL) BENCENOSULPHONAMIDE AS A NACHR ALFA MODULATOR
BR112017020180A2 (en) tetrahydrofuran-fused aminohydrothiazine derivatives that are useful in the treatment of alzheimer's disease
SV2017005527A (en) THERAPEUTIC AGENT FOR FRONT LOBBUS DYSFUNCTION
AR105106A1 (en) DERIVATIVES OF 1,3-OXAZIN-4-ONA AS ALLOSTERIC MODULATORS OF THE M1 MOLINARY MUSCARINIC RECEIVER